Skip to content

Clinical trials

Phase 2/3 COVID-19 trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Phase: Phase 2/3 Country / region: Italy Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
202012
20215
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated5
Unknown status4
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Dompé Farmaceutici S.p.A2
Merck Sharp & Dohme LLC2
Abivax S.A.1
Ansun Biopharma, Inc.1
Fabrizio Cantini1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
Gilead Sciences1
Hellenic Institute for the Study of Sepsis1
Hospital of Prato1
NEAT ID Foundation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-1919
Coronavirus Infections3
Pneumonia3
Communicable Diseases, Emerging1
Hypoxia1
Infections1
Post-Acute COVID-19 Syndrome1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.